Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.24−0.08 (-0.60%)
Close on Nov 20, 2026Market cap $144.13MP/E –Yield –
Burning Rock Biotech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -CN¥54.85M. The highest annual figure on record is -CN¥54.85M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CN¥54.85M | – |
| FY2024 | Dec 31, 2024 | -CN¥357.56M | – |
| FY2023 | Dec 31, 2023 | -CN¥669.32M | – |
| FY2022 | Dec 31, 2022 | -CN¥980.41M | – |
| FY2021 | Dec 31, 2021 | -CN¥797.06M | – |
| FY2020 | Dec 31, 2020 | -CN¥412.41M | – |
| FY2019 | Dec 31, 2019 | -CN¥169.09M | – |
| FY2018 | Dec 31, 2018 | -CN¥161.40M | – |
See a number that looks wrong?